Hawaii Biotech, Inc. (HBI) is a privately held biotechnology company focused on the research and development of vaccines for established and emerging infectious diseases. The company has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. Current vaccine candidates in clinical or pre-clinical development target the West Nile virus, Tick borne flaviviruses, Zika virus, Crimean-Congo hemorrhagic fever virus, and Chikungunya virus. HBI’s drug development activities are focused on small molecule drugs that block intracellular and extracellural bacterial toxins. Product opportunities include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company also partners its proprietary saponin adjuvant for vaccine development.
Company Details
- Employees
- 16
- Founded
- -
- Address
- 650 Iwilei Road,
- Phone
- 8087921343
- in****@****ech.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- hibiotech.com
- HQ
- Honolulu, Hawaii
Hawaii Biotech, Inc. Questions
Hawaii Biotech, Inc.'s helpline number is 8087921343
Hawaii Biotech, Inc.'s website is hibiotech.com
Hawaii Biotech, Inc.'s LinkedIn profile is https://www.linkedin.com/company/hawaii-biotech
Hawaii Biotech, Inc. has
16 employees.
View email and phone details for 16
employees at Hawaii Biotech, Inc..
Hawaii Biotech, Inc.'s industry is
Biotechnology Research
Hawaii Biotech, Inc.'s top competitors are
Clinical Labs Of Hawai'i, Llp,
Cardax, Inc.,
Moana Technologies Llc,
Neurelis, Inc.,
Capture Diagnostics, Llc,
Nextgen Laboratories,
Pacific Biotech Sas,
Global Algae,
Hawaii Isotope Technology,
Cellana Inc..
Hawaii Biotech, Inc.'s support email address is info@hibiotech.com
Hawaii Biotech, Inc.'s categories are Biotechnology Research
Hawaii Biotech, Inc.'s founding year is 1982
